Equine echocardiography: Can dobutamine infusion correct alterations due to sedation with alpha-2 agonists?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
04
2022
accepted:
03
10
2022
entrez:
18
10
2022
pubmed:
19
10
2022
medline:
21
10
2022
Statut:
epublish
Résumé
For the echocardiographic examination horses should not be sedated unless absolutely necessary because this alters cardiac dimensions and indices of function. However, some horses do not tolerate the echocardiographic procedure and require sedation to conduct the examination safely and obtain good quality images. The objective of this study was to evaluate whether the concurrent infusion of dobutamine in horses sedated with romifidine counteracts the cardiovascular changes observed with sedation alone. Twelve healthy untrained Standardbred mares were used. Three echocardiographic examinations were performed on the same day for each subject: a) without any treatment under resting conditions (WT); b) under sedation with romifidine administered intravenously (RT); c) under sedation with romifidine and concurrent intravenous infusion with dobutamine (RDT). A three-hour washout period was observed between each examination and the order of the examinations was randomly decided by rolling a dice. The measurements on the images recorded were performed offline at the end of the study protocol and at this point the operator was blinded to the horse and treatment administered. Left ventricular internal diameter (LVID) in diastole, left ventricular free wall (LVFW) in systole, and fractional shortening (FS) were higher in the WT group compared with the other two groups. No differences in the other M-mode and B-mode values were observed. A continuous rate infusion of dobutamine did not counteract the alterations caused by sedation and led to similar echocardiographic measurements to those obtained after romifidine administration.
Identifiants
pubmed: 36256667
doi: 10.1371/journal.pone.0276256
pii: PONE-D-22-09717
pmc: PMC9578622
doi:
Substances chimiques
Dobutamine
3S12J47372
Adrenergic alpha-2 Receptor Agonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0276256Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Berl Munch Tierarztl Wochenschr. 2013 Sep-Oct;126(9-10):436-43
pubmed: 24199387
Vet Rec. 2008 Jul 5;163(1):21-5
pubmed: 18603631
Equine Vet J. 2005 Mar;37(2):128-32
pubmed: 15779624
Vet Clin North Am Equine Pract. 2001 Apr;17(1):179-89, viii
pubmed: 11488043
Vet Anaesth Analg. 2018 Jul;45(4):467-476
pubmed: 29880276
J Vet Intern Med. 2014 May-Jun;28(3):749-61
pubmed: 24628586
Vet Clin North Am Equine Pract. 1985 Aug;1(2):335-52
pubmed: 3878193
J Vet Intern Med. 2006 May-Jun;20(3):562-8
pubmed: 16734090
J Vet Intern Med. 2016 May;30(3):866-72
pubmed: 27059803
Kardiol Pol. 2019 Nov 22;77(11):1011-1019
pubmed: 31647477
Am J Vet Res. 1991 May;52(5):651-7
pubmed: 1854087
Equine Vet J Suppl. 2006 Aug;(36):159-62
pubmed: 17402412
J Vet Emerg Crit Care (San Antonio). 2016 Jan-Feb;26(1):85-92
pubmed: 26488617
Equine Vet J Suppl. 1995 Sep;(19):33-7
pubmed: 8933067
Vet Anaesth Analg. 2007 Jan;34(1):1-8
pubmed: 17238956
J Vet Cardiol. 2008 Jun;10(1):45-51
pubmed: 18511359
Vet J. 2017 Sep;227:8-14
pubmed: 29031332
J Vet Pharmacol Ther. 2012 Oct;35(5):478-88
pubmed: 22233529
J Vet Intern Med. 2006 May-Jun;20(3):575-80
pubmed: 16734092
Eur Heart J. 1997 Jun;18 Suppl D:D9-15
pubmed: 9183605
Equine Vet J Suppl. 2006 Aug;(36):183-92
pubmed: 17402416
J Vet Intern Med. 2003 Jan-Feb;17(1):58-64
pubmed: 12564728
Vet Clin North Am Equine Pract. 2019 Apr;35(1):43-64
pubmed: 30826106